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Abstract: Several studies have described a decreasing trend in amenable mortality, as well as the
existence of socioeconomic inequalities that affect it. However, their evolution, particularly in small
urban areas, has largely been overlooked. The aim of this study is to analyse the socioeconomic
inequalities in amenable mortality in three cities of the Valencian Community, namely, Alicante,
Castellon, and Valencia, as well as their evolution before and after the start of the economic crisis
(2000–2007 and 2008–2015). The units of analysis have been the census tracts and a deprivation index
has been calculated to classify them according to their level of socioeconomic deprivation. Deaths and
population were also grouped by sex, age group, period, and five levels of deprivation. The specific
rates by sex, age group, deprivation level, and period were calculated for the total number of deaths
due to all causes and amenable mortality and Poisson regression models were adjusted in order to
estimate the relative risk. This study confirms that the inequalities between areas of greater and lesser
deprivation in both all-cause mortality and amenable mortality persisted along the two study periods
in the three cities. It also shows that these inequalities appear with greater risk of death in the areas
of greatest deprivation, although not uniformly. In general, the risks of death from all causes and
amenable mortality have decreased significantly from one period to the other, although not in all the
groups studied. The evolution of death risks from before the onset of the crisis to the period after
presented, overall, a general pro-cyclical trend. However, there are population subgroups for which
the trend was counter-cyclical. The use of the deprivation index has made it possible to identify
specific geographical areas with vulnerable populations in all three cities and, at the same time, to
identify the change in the level of deprivation (ascending or descending) of the geographical areas
throughout the two periods. It is precisely these areas where more attention is needed in order to
reduce inequalities.
Keywords: mortality; amenable mortality; socioeconomic factors; economic recession; small-area
analysis; Spain
1. Introduction
Amenable mortality (AM), understood as untimely and unjustified deaths that should not occur
in the presence of timely healthcare procedures to avoid them, is a type of mortality used to assess
the impact of the response and quality of a health system as well as the potential weaknesses of
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its healthcare. Thus, it has also been used during the last decades to evaluate the positive impact
on a population’s health due to the improvements in access, monitoring, diagnosis, and treatment,
particularly in industrial countries [1,2].
For decades, in most European countries the trend of all-cause mortality has been decreasing [3].
Moreover, a progressive decrease in amenable mortality can also be observed in several of these
countries at different rates, depending on the country and population group [4–6]. However, in some
of the lower-income European countries, this trend has tended to change direction in recent years,
particularly in the case of women [7].
In this context, the impact of the economic downturn on health, either due to worsening general
socioeconomic conditions, or due to cutbacks in health services and public investment in health, or
the privatization of health services, is the subject of a growing scientific literature, whose results are
paradoxical. On the one hand, a series of studies indicate that mortality has a pro-cyclical behaviour
against macroeconomic difficulties; that is, the recession, unemployment, etc., cause an improvement
in certain healthy habits; such as quitting smoking, cooking at home, playing sports, or visiting family
and friends that improve living conditions and reduce mortality, while economic booms increase
mortality [8,9]. On the other hand, economic crises can exacerbate poverty levels or stress and
therefore increase morbidity and mortality in a counter-cyclical trend. Sometimes pro-cyclical and
counter-cyclical effects operate sequentially [10] or at different rhythms, in the short and long term [7].
Some authors who provide pro-cyclical results warn that while a recession can reduce death rates in the
general population, they can worsen in specific social sectors or geographical areas [11]. This shows
the need to study socioeconomic inequalities in health in general, and in mortality in particular [12,13].
Within this growing scientific interest, various studies have investigated the impact of the economic
slowdown on the population’s health and healthcare, both in Spain [14–16] and in other European
countries [7,17–19], as well as in other continents [20,21]. The 2008 economic crisis coincided with the
implementation of austerity policies that reduced the capacity of the Spanish public health system.
This reduction struck unevenly depending on the position of the people and social groups in the
social structure and depending on geographical location (rural/urban, centre/peripheral, outskirts, etc.).
Therefore, as amenable mortality depends directly on the response capacity of the health system, its use
is not only relevant as an indicator of the crisis impact, but also as an indicator of the inequalities of that
impact at different socioeconomic or educational levels, sex/gender, age, ethnic group, or geographical
area; so reveal recent studies in Spain [6,22] and Europe [23].
These inequalities in socioeconomic level or access to health services are in themselves a risk
factor, and therefore it is necessary to study them in order to identify the most vulnerable groups or
geographical areas to carry out specific interventions [24]. An adequate instrument to study health
inequalities and the effects of economic downturns is the deprivation index (DI). Designed to measure
the disadvantages of an individual, a family, or a group with regard to their community, or society, they
are usually built from various indicators [25]. In Spain, a DI has been devised within the framework of
the MEDEA projects [26]. This index, based on census data, has allowed the census tracts to be classified
according to their level of socioeconomic deprivation, and its usefulness has been demonstrated in
several studies on inequalities in mortality in urban areas [19,27,28].
In Europe, some studies on socioeconomic inequalities in amenable mortality at the country
level or comparisons between countries have been carried out [4,29,30]. However, few studies have
researched these inequalities at the urban level, and there is no evidence that the changes in these
inequalities have been studied after the start of the 2008 economic slowdown. Therefore, the objective
of this article is to analyse the socioeconomic inequalities in amenable mortality in the three most
important cities of the Valencian Community (Spain), and their evolution after the start of the 2008
economic crisis, taking the census tract as the basic geographic unit.
The main hypothesis is that the economic crisis did not affect all social groups in the same way.
This differentiation in impact might depend on multiple factors, ranging from the duration of the
crisis in the different economic areas to the position of the different census tracts in the socioeconomic
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structure, and that of the families and individuals that inhabit them; also, the different actors’ responses
(State, institutions, political parties, unions, families, and individuals) vis-a-vis the crisis and the crisis
victims’ needs.
2. Materials and Methods
2.1. Design, Study Population, and Unit of Analysis
This is an ecological analysis of AM comparing two periods: 2000–2007 and 2008–2015. The units
of analysis were the census tracts (CTs) of the cities of Alicante (178 CTs), Castellon (58 CTs), and
Valencia (531 CTs). A census tract, in the different countries where it is used, is the smallest territorial
unit, established for operational purposes, for which statistical data is available. In Spain, a CT average
population is 1000 inhabitants. These three cities are located in the Autonomous Community of
Valencia, with an average annual total population (in all three cities) of 1,240,744 inhabitants during
the period 2000–2007 and 1,310,123 in the period 2008–2015.
2.2. Mortality Data
All deaths of residents in these cities in the study periods have been included in the research.
The death data were taken from the Mortality Registry of the Valencian Community, obtaining the
variables year of death, age, sex, city (Alicante, Castellón, and Valencia), and cause of death. The causes
of death used in the analysis were coded according to the International Classification of Diseases, Tenth
Revision (ICD-10). The causes of amenable deaths analysed in the study were those proposed by Nolte
and McKee [1] (see Table A1 of Appendix A), and following the criteria defined by these authors. It is
important to notice that only 50% of the deaths due to ischaemic heart disease were included [2,31].
All deceases were georeferenced and assigned to their CT of residence. The data were obtained from
an anonymized database maintained by the Mortality Registry of the Autonomous Community of
Valencia. Since the study was based on retrospective administrative data, the approval of an ethics
committee in Spain was not required.
2.3. CTs by Socioeconomic Deprivation Level
A deprivation index (DI) for each CT, in all three cities and periods, was established using the
following indicators (in percentage): (i) unemployment, (ii) manual workers, (iii) casual workers,
(iv) insufficient education in young people (16 to 29 years), and (v) insufficient education in general.
These indicators have already been proposed in the calculation of deprivation index (DI) on the basis
of census data in major Spanish cities as the first component of a principal component analysis [26].
For our research, indicator data were obtained from the 2001 Population and Housing Census for
the period 2000–2007, and from the 2011 Population and Housing Census for the period 2008–2015.
The deprivation index used was developed within the framework of the MEDEA3 project (third
edition of the national coordinated MEDEA project) from which the study data, both on socioeconomic
inequality and mortality, stem.
For each period and city, the 10 (P10), 25 (P25), 75 (P75), and 90 (P90) DI percentiles were calculated.
Thus, classifying the census tracts into five deprivation levels (DL) according to their value; that is,
DL1, DI values lower than P10; DL2, DI values between P10 and P25; DL3, DI values between P25 and
P75; DL4, DI values between P75 and P90; and DL5, DI values greater than P90.
Figure 1 shows the census tract distribution in the three cities in relation to their DL.
This classification was outlined according to the aim of this research in order to quantify the difference
in risks between the most socioeconomically favoured areas (DL1) and those of greatest deprivation
(DL5). Table A2 of Appendix A shows the average values of the five socioeconomic indicators used
in the different DLs of each city and period under study. In addition, the DI calculated for the two
periods has made visible the changes that have occurred over time in the three cities (see Figure 1).
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2.4. Population Data
The population data (by CT, year, age, and sex) used in order to calculate mortality indicators
(rates and the relative risks) for the periods studied were obtained with permission from the Valencian
Institute of Statistics, which is responsible for compiling population statistics in this region. Table A3
of Appendix A shows the average annual population for all the cities under study by sex, age group,
DL, and period.
2.5. Data Analysis
To study the evolution of the risk of death over time, the data were classified into two periods:
2000–2007 (P1) and 2008–2015 (P2). Deaths were also grouped by three age ranges: 0–44, 45–64, and 65
and older.
The specific rates by sex, age group, DL, and period have been calculated for the total number
of deaths due to all causes and the total amenable mortality. In order to estimate the relative risks
(RRs) between the categories of the variables under study, the Poisson regression models also have
been adjusted, taking into consideration the city, age, DL, and period effects, separated by sex, and
carrying out a robust estimation to control the possible over-dispersion of the data. In addition, the
proportional mortality of the large ICD-10 groups was calculated according to sex and deprivation
level for all three cities so as to compare the pattern of mortality by groups of causes according to
period. Finally, the program IBM® SPSS® Statistics (v.25) (Armonk, NY, USA) and our own software
were used for calculating the mortality indicators.
3. Results
Between 2000 and 2015 there occurred 177,583 deaths in all three cities under study (40,774 in
Alicante, 20,935 in Castellón, and 115,874 in Valencia). Nevertheless, 2634 of these (1.5%) could not
be georeferenced and assigned to the census section of residence as the deceased person’s residence
address was not stated or did not correspond to the cities under study. Regarding the remaining
174,949 that could be georeferenced, 86,479 occurred in the period 2000–2007 and 88,470 in 2008–2015.
Tables A4 and A5 of Appendix A show the death frequencies and percentages for the specific causes of
amenable mortality and the chapters of the ICD-10, according to period, DL, and sex.
In Table 1, the average values and confidence interval of the DI are displayed. In it, it can be seen
that the average values per DI varied scarcely from the period 2000–2007 to the period 2008–2015.
The city of Castellón, for instance, showed smaller differences in the averages observed between the
more extreme DLs, but similar in the rest of DLs. The table also includes the number of sections for
each of the DLs in each city and all cities as a whole. Observing Table A2 of Appendix A, it can be
noticed that areas with DL5 are areas with an alarming situation, where all the indicators used to
build the index appear in high values: areas hit by unemployment, lack of training, school dropout,
precarious work, and so on.
In order to verify if the effects of DL, period, and age group on mortality risk were significantly
different according to city, the Poisson models were adjusted, including the effects of the following
variables: city, DL, period, age group, and the interactions between the city and the rest of the other
variables, verifying the absence of statistical significance of the terms of the interaction of the city effect
with the other effects.
All interactions were not significant for both all-cause mortality (in men, p = 0.569 interaction
with DL, p = 0.195 with period and p = 0.160 with age; in women p = 0.491 with DL, p = 0.070 with
period and p = 0.101 with age) and mortality due to amenable causes (in men, p = 0.711 interaction
with DL, p = 0.186 with period and p = 0.599 with age; in women p = 0.771 with DL, p = 0.632 with
period and p = 0.072 with age). Due to the absence of a significant interaction, the estimation of effects
was carried out jointly for the three cities under study.
Int. J. Environ. Res. Public Health 2020, 17, 6489 6 of 28
Table 1. Descriptive characteristics of the deprivation index according to deprivation levels for the
census sections of each city and all three cities.
Town
Deprivation
Level (DL) a
Number of
Census
Tract
2008–2015 (2011 Census) 2000–2007 (2001 Census)
Mean
95% CI
Mean
95% CI
Lower
Limit
Upper
Limit
Lower
Limit
Upper
Limit
Alicante
DL1 17 −0.84 −0.88 −0.79 −0.80 −0.85 −0.76
DL2 27 −0.56 −0.60 −0.52 −0.52 −0.56 −0.47
DL3 90 0.00 −0.04 0.04 0.01 −0.03 0.05
DL4 27 0.44 0.40 0.47 0.42 0.38 0.46
DL5 17 1.03 0.80 1.25 0.92 0.77 1.06
Total 178 0.00 −0.08 0.08 0.00 −0.07 0.07
Castellón
DL1 5 −0.55 −0.60 −0.49 −0.67 −0.80 −0.54
DL2 9 −0.41 −0.45 −0.37 −0.41 −0.45 −0.38
DL3 30 −0.01 −0.08 0.06 −0.03 −0.10 0.03
DL4 9 0.41 0.37 0.45 0.47 0.38 0.55
DL5 5 0.61 0.48 0.74 0.77 0.55 0.98
Total 58 0.00 −0.10 0.10 0.00 −0.11 0.11
Valencia
DL1 53 −0.72 −0.74 −0.70 −0.78 −0.80 −0.75
DL2 79 −0.49 −0.51 −0.47 −0.50 −0.52 −0.48
DL3 266 −0.01 −0.04 0.01 0.00 −0.02 0.03
DL4 80 0.44 0.42 0.46 0.46 0.44 0.47
DL5 53 0.85 0.80 0.91 0.82 0.77 0.87
Total 531 0.00 −0.04 0.04 0.00 −0.04 0.04
All cities
together
DL1 75 −0.74 −0.76 −0.71 −0.78 −0.80 −0.75
DL2 115 −0.50 −0.52 −0.48 −0.50 −0.51 −0.48
DL3 386 −0.01 −0.03 0.01 0.00 −0.02 0.02
DL4 116 0.44 0.42 0.45 0.45 0.43 0.46
DL5 75 0.88 0.81 0.94 0.84 0.79 0.89
Total 767 0.00 −0.03 0.03 0.00 −0.03 0.03
a DL: Deprivation level of the census tract of residence based on the deprivation index (DI). DL1: DI < P10; DL2:
P10 ≤ DI < P25; DL3: P25 ≤ DI < P75; DL4: P75 ≤ DI < P90; DL5: DI ≥ P90. Pq = Percentile q.
In the joint analysis of the three cities, the Poisson regression models were adjusted by sex. These
included the effects of the following variables: DL, period, age group, the first-level interactions
between DL and the rest of the other variables, and also the second-level interaction between DL,
period, and age. These models suggested the existence of a significant (p< 0.05) second-level interaction
between the DL effect, period, and age group in both men and women. Figures 2 and 3 show the
specific rates by sex, age group, period, and DL for all causes and amenable mortality (the values of
the rates can be observed in Tables A6 and A7 of Appendix A).
Mortality graphs for overall and amenable mortality suggest that the mortality rates are generally
higher at the levels of greatest economic deprivation. The detected interaction could be due to some
exceptions to this general behaviour. Thus, for general mortality in men in the age group of over 65
there are hardly any differences in rates according to the DL in the period 2000–2007, while, on the
contrary, regarding amenable mortality in men aged 0–44 years, there are. In women, the age group 65
and over has not experienced increases in rates according to the DL for general mortality in any period,
unlike for amenable mortality.
Due to the existence of an interaction, the relative risks between categories of DL (a measure of
inequality according to DL) specific by sex, age, and period were estimated using a simple Poisson
model with DL as the only effect. To estimate the increase or decrease in the risks of death of one to
another period, a simple Poisson model specific by sex, age, and DL was adjusted with period as the
only effect.
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Regarding mortality from all causes, as Table 2 shows, the risk of death increased as the DL
worsened, in the younger age groups (0–44 and 45–64 years), both in men and women (the significant
RRs were greater than 1 in the highest categories, DL5 and DL4, when compared with DL1), and
both in the first and second period under study. Nevertheless, in the 0–44 age group, the RRs were
higher for men in the first period and women in the second, suggesting a tendency towards decreasing
inequalities in men and increasing in women. The behaviour of the mortality risks in the age group of
65 years of age and over was different, since only the RRs significantly higher than 1 occurred in men in
the second period, whereas regarding women only the relative risk of the DL2 group was significantly
higher in the first period. Regarding the evolution from the first to the second period, overall, the risk
of death decreased, with the RRs adjusted by age in the second period as compared to the first period
of 0.875 (95% CI: 0.833–0.919) in men and 0.961 (95% CI: 0.945–0.977) in women.
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Table 3 shows the RR of the 2008–2015 period vis-a-vis the 2000–2007 period. In men, a significant
overall decrease in the risk of death in all categories of DL (except in DL4 and DL5 for the age group of
65 and over) can be seen. However, there was no significant drop in the risk of death at levels DL4
(ages 45–64 and 65 and more) and DL5 (all ages) and in DL1 (ages 45–64 and 65 and more) in women
and in DL5 and DL4 (age 65 and over) in men. This means that men and women of these age groups
and DL did not improve the risk of death from all causes.
Regarding mortality due to amenable causes, according to Table 4, the risks of death increased in
women, for any age, in both periods, as the DL worsened. However, in men, the behaviour of this
variable was different depending on the age group. In the group of 0–44 years of age, the RRs went
from being lower than 1 (therefore lower risk of death in any category of DL than in DL1) in the first
period to RRs greater than 1 in the worst DL categories (DL5 and DL4) in the second period. Although
this suggests a tendency to increase inequality, these results were not significant. In addition, in the
intermediate age group (45–64 years), the RRs were significantly higher than 1 in the most deprived
DL categories (DL5 and DL4) in both periods. Finally, in the group of seniors (65 and over), the RRs
increased slightly in the second period.
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Table 2. Relative risk of death for all causes according to the level of deprivation and 95% confidence
intervals (95% CI) specific by age, sex, and period.
Sex Age
Deprivation
Level (DL) a
2000–2007 2008–2015
RR
95% CI
RR
95% CI
Lower Upper Lower Upper
Men
0–44
DL5 2.034 1.708 2.434 1.582 1.263 1.997
DL4 1.504 1.269 1.793 1.365 1.097 1.713
DL3 1.196 1.024 1.406 1.040 0.853 1.282
DL2 1.168 0.981 1.397 0.881 0.705 1.110
DL1 1 . . 1 . .
45–64
DL5 1.697 1.525 1.890 1.535 1.369 1.724
DL4 1.372 1.242 1.519 1.427 1.283 1.591
DL3 1.168 1.068 1.279 1.146 1.041 1.264
DL2 1.009 0.911 1.119 0.871 0.781 0.974
DL1 1 . . 1 . .
≥65
DL5 1.015 0.966 1.066 1.226 1.166 1.289
DL4 0.963 0.920 1.008 1.135 1.083 1.190
DL3 0.983 0.945 1.023 1.068 1.025 1.113
DL2 0.979 0.935 1.025 1.014 0.968 1.062
DL1 1 . . 1 . .
Women
0–44
DL5 1.557 1.202 2.030 1.933 1.401 2.711
DL4 1.327 1.041 1.706 1.422 1.037 1.984
DL3 1.142 0.922 1.434 1.294 0.977 1.756
DL2 1.074 0.841 1.383 1.096 0.802 1.524
DL1 1 . . 1 . .
45–64
DL5 1.473 1.257 1.727 1.372 1.174 1.606
DL4 1.262 1.092 1.463 1.198 1.038 1.386
DL3 1.102 0.971 1.254 0.989 0.873 1.124
DL2 1.113 0.964 1.287 0.882 0.765 1.018
DL1 1 . . 1 . .
≥65
DL5 1.000 0.955 1.048 1.010 0.964 1.058
DL4 1.015 0.972 1.060 0.986 0.945 1.028
DL3 0.996 0.960 1.034 0.978 0.944 1.014
DL2 1.087 1.042 1.133 1.024 0.983 1.067
DL1 1 . . 1 . .
Note: a DL: Deprivation level of the census tract of residence based on the deprivation index (DI). DL1: DI < P10;
DL2: P10 ≤ DI < P25; DL3: P25 ≤ DI < P75; DL4: P75 ≤ DI < P90; DL5: DI ≥ P90. Pq = Percentile q.
Comparing period 2008–2015 with period 2000–2007, it can be seen that the risk of death decreased,
with RRs adjusted by age of 0.725 (CI95%: 0.659–0.798) in men and 0.785 (CI95%: 0.741–0.831) in women.
Table 5 shows the RRs of the period 2008–2015 as compared to the period 2000–2007. A significant
reduction in the risks of death in most of the DL categories can be observed, although with some
exceptions, since no significant drop was observed in men of 0–44 years of age in DL1, DL4, and
DL5 and of 45–65 years in DL1 and DL4, nor in women of 0–44 years in DL1, DL2, and DL4 and of
45–65 years in DL1, DL4, and DL5. In addition, there was an upsurge (not significant) in the risk of
death (RR > 1) at the DL4 level in men of 45–64 years and in DL5 in women of 0–44 years.
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Table 3. Relative risk of death for all causes in the 2008–2015 period versus the 2000–2007 period and
95% confidence intervals (95% CI) specific for age, sex, and deprivation level.
Deprivation
Level (DL) a
Age
Men Women
RR
95% CI
RR
95% CI
Lower Upper Lower Upper
DL1
0–44 0.720 0.562 0.918 0.671 0.470 0.946
45–64 0.863 0.761 0.977 1.042 0.882 1.232
≥65 0.829 0.786 0.874 0.993 0.947 1.041
DL2
0–44 0.543 0.467 0.631 0.684 0.556 0.840
45–64 0.745 0.684 0.811 0.826 0.736 0.927
≥65 0.859 0.826 0.892 0.935 0.904 0.968
DL3
0–44 0.626 0.577 0.680 0.760 0.678 0.851
45–64 0.846 0.810 0.885 0.936 0.876 0.999
≥65 0.901 0.882 0.920 0.975 0.956 0.995
DL4
0–44 0.654 0.568 0.751 0.718 0.582 0.885
45–64 0.897 0.829 0.970 0.990 0.878 1.115
≥65 0.977 0.940 1.016 0.964 0.929 1.001
DL5
0-44 0.560 0.479 0.653 0.832 0.657 1.053
45–64 0.780 0.709 0.859 0.972 0.838 1.127
≥65 1.002 0.957 1.049 1.002 0.958 1.049
Note: a DL: Deprivation level for the census tract of residence based on the deprivation index (DI). DL1: DI < P10;
DL2: P10 ≤ DI < P25; DL3: P25 ≤ DI < P75; DL4: P75 ≤ DI < P90; DL5: DI ≥ P90. Pq = Percentile q.
Table 4. Relative risk of death by amenable causes of death according to deprivation level and 95%
confidence intervals (95% CI) specific for age, sex, and period.
Sex Age
Deprivation
Level (DL) a
2000–2007 2008–2015
RR
95% CI
RR
95% CI
Lower Upper Lower Upper
Men
0–44
DL5 0.997 0.659 1.519 1.256 0.742 2.195
DL4 0.869 0.593 1.292 1.419 0.876 2.405
DL3 0.835 0.605 1.183 1.061 0.686 1.736
DL2 0.979 0.678 1.437 0.884 0.538 1.514
DL1 1 . . 1 . .
45–64
DL5 2.079 1.607 2.710 1.364 1.046 1.789
DL4 1.491 1.165 1.925 1.474 1.160 1.891
DL3 1.345 1.080 1.696 1.049 0.846 1.318
DL2 1.254 0.979 1.620 0.775 0.602 1.005
DL1 1 . . 1 . .
≥65
DL5 1.177 0.971 1.429 1.238 0.983 1.564
DL4 1.090 0.910 1.311 1.297 1.052 1.608
DL3 1.099 0.939 1.294 1.112 0.925 1.350
DL2 1.002 0.834 1.209 .960 0.774 1.196
DL1 1 . . 1 . .
Int. J. Environ. Res. Public Health 2020, 17, 6489 11 of 28
Table 4. Cont.
Sex Age
Deprivation
Level (DL) a
2000–2007 2008–2015
RR
95% CI
RR
95% CI
Lower Upper Lower Upper
Women
0–44
DL5 1.507 0.905 2.564 1.932 1.143 3.413
DL4 1.673 1.063 2.735 1.405 0.840 2.464
DL3 1.364 0.908 2.154 1.148 0.727 1.931
DL2 1.345 0.851 2.205 1.268 0.772 2.195
DL1 1 . . 1 . .
45–64
DL5 1.347 1.040 1.748 1.696 1.286 2.250
DL4 1.153 0.912 1.466 1.378 1.064 1.801
DL3 1.016 0.831 1.254 1.110 0.885 1.411
DL2 1.109 0.883 1.402 1.033 0.801 1.346
DL1 1 . . 1 . .
≥65
DL5 1.665 1.338 2.083 1.665 1.284 2.173
DL4 1.384 1.118 1.723 1.394 1.089 1.798
DL3 1.251 1.037 1.523 1.367 1.102 1.718
DL2 1.062 0.853 1.330 1.309 1.026 1.684
DL1 1 . . 1 . .
Note: a DL: Deprivation level of the census tract of residence based on the deprivation index (DI). DL1: DI < P10;
DL2: P10 ≤ DI < P25; DL3: P25 ≤ DI < P75; DL4: P75 ≤ DI < P90; DL5: DI ≥ P90. Pq = Percentile q.
Table 5. Relative risk of death for amenable causes of death in the 2008–2015 period versus the
2000–2007 period and 95% confidence intervals (95% CI) specific by age, sex, and deprivation level.
Deprivation
Level (DL) a
Age
Men Women
RR
95% CI
RR
95% CI
Lower Upper Lower Upper
DL1
0–44 0.598 0.343 1.010 0.953 0.508 1.761
45–64 1.060 0.786 1.429 0.765 0.571 1.021
≥65 0.640 0.507 0.806 0.681 0.516 0.896
DL2
0–44 0.540 0.382 0.757 0.899 0.641 1.260
45–64 0.655 0.536 0.799 0.713 0.589 0.863
≥65 0.613 0.518 0.724 0.839 0.697 1.011
DL3
0–44 0.760 0.626 0.921 0.802 0.656 0.980
45–64 0.827 0.744 0.918 0.836 0.748 0.935
≥65 0.648 0.593 0.708 0.745 0.674 0.823
DL4
0–44 0.976 0.695 1.370 0.801 0.559 1.141
45–64 1.048 0.873 1.258 0.914 0.746 1.121
≥65 0.761 0.650 0.890 0.686 0.571 0.823
DL5
0–44 0.753 0.493 1.142 1.223 0.799 1.884
45–64 0.695 0.554 0.871 0.963 0.752 1.234
≥65 0.673 0.554 0.816 0.681 0.555 0.835
Note: a DL: Deprivation level for the census tract of residence based on the deprivation index (DI). DL1: DI < P10;
DL2: P10 ≤ DI < P25; DL3: P25 ≤ DI < P75; DL4: P75 ≤ DI < P90; DL5: DI ≥ P90. Pq = Percentile q.
4. Discussion
4.1. Summary of Findings: Inequalities and Evolution of Death Risk
This study has shown that the inequalities between areas of greater and lesser deprivation in both
all-cause mortality and amenable mortality persist along the two study periods in the three cities, and
that these inequalities appear with greater risk of death in the areas of greatest deprivation, although
they present nuances depending on whether it is all-cause or amenable mortality, level of deprivation,
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age group, sex, or period. It has been found that, in general, the risks of death from all causes and
amenable mortality have decreased significantly from one period to the other, although not in all the
groups studied.
4.2. Inequalities
4.2.1. Overall Mortality
Inequalities in all-cause mortality among levels of deprivation have not disappeared. In some
cases, although inequalities remain, the RRs have decreased for both men and women, showing in
most cases a clear gradient between the most impoverished and the most favoured levels. However, in
some age groups, such as men 65 and over and women 0–44, inequalities have increased. In the case of
younger men (0–44 and 45–64), inequalities tend to decrease. This result could indicate that men of
working age are the recipients of pro-cyclical impacts on health. The reasons may be related to the
reduction of work stress due to increased unemployment [32,33], in the specific Valencian case, due to
the bursting of the housing bubble or a decrease in tobacco consumption [34], as well as the general
decrease in pollution from industrial activity [35]. In other words, with the economic contraction, an
overall reduction in mortality risks can be observed in men of working age. This process might have
developed, to a greater extent, among the most deprived sectors, highly affected by unemployment.
The analysis on the effects of pro-cyclical and counter-cyclical mechanisms proposed by Catalano
et al. [33] is appropriate here.
In the case of men over 65, inequalities appear in the second period, while in the first period they
were non-existent. This could be due to the fact that the economic crisis deteriorated the socioeconomic
conditions of the census sections that already had high levels in all the deprivation indicators, in all
three cities. This could have directly affected the age cohorts who had not yet retired, men in the later
years of the working age—a situation aggravated by the feeling of not being able to fulfil the traditional
provider role. This sector of men was most affected by the crisis, with deficiencies in unemployment
benefits and in which the effects of this appear in the short but also in the long term, or even with
permanent consequences of increased mortality, as found by Bender et al. in Greece [36].
In the case of women, inequalities persist, although not in all age groups. In women aged 65
and over, there are no inequalities in general mortality in either of the two periods, whereas in the
youngest (0–44) these inequalities increase. In older women, this could be due, in part, to the fact that
in the life cycle of women they achieve economic stability and establish social and family capital as
they age. Furthermore, although they do not have social capital around them, both the legislative
body and the institutions offer them different forms of protection. However, in the case of younger
women (0–44), inequalities not only persist but tend to increase, particularly in the most disadvantaged
groups. This may be due to the fact that women of this age are one of the most vulnerable sectors
in times of crisis as they suffer more severely (they or their families, on whom they depend in the
case of being minors or not being economically independent), due to unemployment, job insecurity,
and various aspects of the so-called feminization of poverty or the intersection between poverty and
gender [37]. During childbearing age, childcare can distance them from full inclusion in the labour
market or the training necessary for reincorporation when the children have grown up. In the case
of single-parent households, they can also bear the double burden of work and the care of children
alone. This period, which can last up to two decades, depending on the number of children and the
spacing between births, constitutes in itself an element of exclusion for all women, even those of the
least deprived levels. In this sense, the risks of death may be related to the mechanisms of stress and
frustration-aggression, and although this is shared by women of all classes, it could more sharply affect
women from the most disadvantaged DLs.
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4.2.2. Amenable Mortality
In general terms, the existence of inequalities by age group, sex, and level of deprivation can be
seen. In young men (0–44 years), inequality, practically non-existent in the first period, appears in
the second, although it does not reach statistical significance. Regarding the men of intermediate age
(45–64) in the first period, a clear gradient of inequality in mortality is perceived, which decreases in
the second period. At these ages, paradoxically, unemployment can increase healthy habits (consume
less tobacco, alcohol, stress reduction, and sports) and reduce deaths from some amenable causes, such
as cardiovascular disease. In the case of the elderly (≥65), an increase in the inequalities towards old
age can be perceived from the first to the second period. The combination of the factors mentioned
above can influence this age.
In the case of women, inequalities in amenable mortality persist over time. Furthermore, some
significant increases in RRs can be seen, i.e., regarding younger women (0–44) in DL5 and women
aged 45–64 years in DL4 and DL5. This is consistent with what has been said previously in relation
to the all-cause mortality over the life cycle of women. In older women (≥65), inequalities persist
with similar gradients in the two periods. This may be because women of these ages do not see their
personal economic situation directly affected by the economic downturn as their pensions are not
affected, as described above. On the other hand, an increase in the malignant neoplasm of the colon and
rectum, as well as malignant neoplasm of cervix uteri is also perceived (see Table A5 of Appendix A).
In this combination of simultaneous or successive pro-cyclical and counter-cyclical trends, short or
long term, many of the mechanisms of stress, frustration-aggression, or effect budgeting described by
Catalano et al. [33] might be at work.
In summary, the patterns of socioeconomic inequality in amenable mortality show some remarkable
differences from those of general mortality. In women, the most notable difference occurs in the group
over 65 years of age, for which the inequalities in amenable mortality remain over the two periods,
whereas inequalities in general mortality are not observed in any of the periods. In the rest of the
age groups, amenable mortality is similar to the overall mortality, with inequalities in both periods.
In the case of men aged 0–44 years, amenable mortality presents inequalities in the second period
that did not exist in the first one, while in overall mortality the inequalities remained over the two
periods, although with a slight decrease. In the 45–64-year-old group, inequalities were observed in
both amenable and general mortality. Finally, in those over 65 years of age, while inequalities are
observed in overall mortality in the second period, the inequalities in amenable mortality were similar
in both periods.
4.3. Evolution of the Risk of Death
Although both all-cause and amenable mortality have decreased, amenable mortality shows a
more pronounced decreasing trend. This pattern had already been described in a similar way in other
studies in Europe [23,38,39]. In the Spanish case, this might suggest that the decrease could be due
to preventive measures in risk factors and advances in treatments and health technology [6], as well
as the entry into force of law 42/2010 on sanitary measures against smoking that regulates the sale,
supply, consumption, and advertising of tobacco [34,40].
This decline in all-cause and amenable mortality in times of crisis also seems to corroborate
pro-cyclical theories of health. Although this may be so in macro-economic terms, the study of
inequalities taking into account both social structure and territory allows us to identify, as in the
previous paragraphs, the population groups in which the pro-cyclical decrease in all-cause or amenable
mortality is not as pronounced. Furthermore, this is even for the groups in which mortality would have
risen, although not significantly, in a counter-cyclical manner, i.e., men older than 65 years, women
older than 45 years in the most deprived levels, or women older than 45 years in the level of least
deprivation, for all causes; and middle-aged men in low deprivation and high deprivation, and young
women in greater deprivation for amenable mortality.
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In general terms, as some authors argue, infra-housing, mental disorders, drug addiction, waiting
lists, energy poverty, or evictions increase the risks of death [41] and must be analysed at their
simultaneous intersection with health [42]. All these processes, present in the cities studied, also
validate the counter-cyclical theory. For these reasons, it is important to include inequality in the
analysis, and to take into account both pro-cyclical and counter-cyclical trends [11], so that the
macro-figure does not hide the reality of the sectors that suffer from the countercyclical trend.
4.4. Impact of the Crisis and Hypotheses
Despite the general decrease in amenable mortality, socioeconomic inequalities have remained
along the two research periods. This study has been carried out in urban areas of the same region, with
common health policy and management, and where access to healthcare was universal during the
first period. The start of the crisis meant the widespread application of cuts in healthcare investment,
outsourcing of services, exclusion of social sectors from public healthcare, or increased difficulties in
accessing it [43].
In this context, the endurance of inequality along the two periods could be due to complex
reasons. On the one hand, the impact of health cuts could have affected, to a greater extent, the
most disadvantaged population groups, preventing a possible reduction of inequalities. On the other,
the results obtained are consistent with other studies carried out in Spain. In them, an effect of the
socioeconomic level on mortality was observed independent from that of health care, based on the
differences in access to and quality of health care, as previously suggested [6], or the lower participation
by the most disadvantaged population in early detection programs (screening programs) of some
diseases, such as breast cancer or colon cancer [44,45].
In addition, it should be borne in mind that the prevalence, incidence, and natural course of some
diseases could have an effect on amenable mortality and differ between socioeconomic levels, as their
risk factors also differ. On the other hand, survival after treatment could be affected by characteristics of
individuals related to their socioeconomic level (social support, resources at home, additional medical
insurance, etc.), although these variables have not been considered in this study. In any case, amenable
mortality proves to be a useful indicator of the degree of efficiency of health systems, also in times
of crisis. Failure to reduce or increase amenable mortality is generally accepted as a deterioration
of healthcare.
4.5. Methodological Strengths and Limitations
This research has the usual limitations of ecological studies. Thus, it is not possible to infer a
causal association. The relationship obtained between the DL and the risks of death when using the
CTs may not be applicable at the individual level (i.e., ecological fallacy), reflecting both the effect of
the individual socioeconomic level and the contextual effect of the area of residence.
The data analysis has been carried out jointly for the three cities. This was mainly due to reasons
of statistical power. However, no important differences have been observed among the three cities
regarding socioeconomic indicators (Table A2 of Appendix A). In addition, the interactions between the
city and the rest of the effects on mortality, such as DL, period, and age, was not significant. Therefore,
a differential effect for each city cannot be stated.
Georeferencing often entails difficulties in this kind of research. In our study, the percentage of
non-georeferenced deaths is 1.3%, lower than usual, and should have little effect on the results.
The list of amenable causes has been chosen for its potential for comparison with previous studies
and also because other lists, even more recent ones, such as that of the AMIEHS project [46], disregards
some causes and might not be appropriate for periods such as 2000–2015. The chosen list includes a
wide number of amenable causes, sensitive to the effects of austerity and cutbacks in healthcare since
the start of the economic crisis in Spain [22].
The inclusion of 50% of deaths from ischemic heart disease could have modified the estimated
RRs among the DLs and between periods, as it is a high-frequency cause. To verify this possibility,
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such RRs were estimated, excluding deaths from this cause. As can be seen in Tables A8 and A9 of
Appendix A, the RRs were hardly modified.
5. Conclusions
This study confirms that inequalities persisted during the two study periods, although they have
not increased in general terms, except in some sectors, such as young women for amenable mortality.
The patterns of inequality evolution showed some differences in amenable mortality and overall
mortality in some groups according to sex and age. Thus, while for women of 65 years of age and over
inequalities in amenable mortality remained over the two periods, inequalities in overall mortality
were not observed in any period. In men, in the group aged 0–44 years, inequalities in amenable
mortality were observed in the second period, while in the group aged 65 and over, amenable mortality
presented similar inequalities in both periods, while general mortality only in the second period.
At the same time, it has also been found that the evolution of death risks from before the onset of
the crisis to the period after the onset presented, overall, a general pro-cyclical trend. However, it has
been possible to identify population subgroups by age, sex, and level of deprivation in which the trend,
on the contrary, would be counter-cyclical (men older than 65 years, women older than 45 years in the
most deprived levels, or women older than 45 years in the level of least deprivation, for all causes;
and middle-aged men in low deprivation and high deprivation, as well as young women in greater
deprivation for amenable mortality).
The use of the deprivation index has made it possible to identify specific geographic areas with
vulnerable populations in all three cities and, at the same time, to identify the change in the level of
deprivation (ascending or descending) of the geographical areas throughout the two periods. It is
precisely in these areas with the greatest deprivation that more studies that deepen the knowledge of
the causes of health inequalities, and those that could indicate the interventions aimed at reducing
these inequalities, are needed.
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Appendix A
Table A1. International Classification of Diseases Codes, 10th revision (ICD-10), and the age ranges for
the amenable causes.
Amenable Causes ICD-10 Age
1 Intestinal infections A00-09 0–14
2 Tuberculosis A15-A19, B90 0–74
3 Other infections (diphtheria, tetanus,poliomyelitis) A36, A35, A80 0–74
4 Whooping cough A37 0–14
5 Septicaemia A40-A41 0–74
6 Measles B05 1–14
7 Malignant neoplasm of colon and rectum C18-C21 0–74
8 Malignant neoplasm of skin C44 0–74
9 Malignant neoplasm of breast C50 0–74
10 Malignant neoplasm of cervix uteri C53 0–74
11 Malignant neoplasm of cervix uteri andbody of uterus C54-C55 0–44
12 Malignant neoplasm of testis C62 0–74
13 Hodgkin’s disease C81 0–74
14 Leukaemia C91-C95 0–44
15 Diseases of the thyroid E00-E07 0–74
16 Diabetes mellitus E10-E14 0–49
17 Epilepsy G40-G41 0–74
18 Chronic rheumatic heart disease I05-I09 0–74
19 Hypertensive disease I10-I13, I15 0–74
20 Ischaemic heart disease (50% of deaths) I20-I25 0–74
21 Cerebrovascular disease I60-I69 0–74
22 All respiratory diseases (excludingpneumonia and influenza) J00-J09, J20-J99 1–14
23 Influenza J10-J11 0–74
24 Pneumonia J12-J18 0–74
25 Peptic ulcer K25-K27 0–74
26 Appendicitis K35-K38 0–74
27 Abdominal hernia K40-K46 0–74
28 Cholelithiasis and cholecystitis K80-K81 0–74
29 Nephritis and nephrosis N00-N07,N17-N19,N25-N27 0–74
30 Benign prostatic hyperplasia N40 0–74
31 Maternal death O00-O99 All
32 Congenital cardiovascular anomalies Q20-Q28 0–74
33 Perinatal deaths, all causes P00-P96, A33, A34 All
34 Misadventures to patients during surgicaland medical care Y60-Y69, Y83-Y84 All
Int. J. Environ. Res. Public Health 2020, 17, 6489 17 of 28
Table A2. Average values of the socioeconomic indicators by city, period, and percentile-based classification of the deprivation index.
Socioeconomic
Indicator
Deprivation
Level (DL) a
Valencia Alicante Castellón
2000–2007
(2001 Census)
2008–2015
(2011 Census)
2000–2007
(2001 Census)
2008–2015
(2011 Census)
2000–2007
(2001 Census)
2008–2015
(2011 Census)
Mean Std.Dev. Mean
Std.
Dev. Mean
Std.
Dev. Mean
Std.
Dev. Mean
Std.
Dev. Mean
Std.
Dev.
People aged 16
or over who
have a manual
job
DL1 0.177 0.034 0.142 0.028 0.230 0.044 0.174 0.045 0.313 0.034 0.276 0.015
DL2 0.276 0.045 0.231 0.040 0.332 0.052 0.298 0.060 0.420 0.044 0.349 0.037
DL3 0.479 0.087 0.444 0.090 0.546 0.087 0.527 0.101 0.575 0.085 0.529 0.087
DL4 0.647 0.045 0.605 0.055 0.686 0.061 0.697 0.066 0.751 0.033 0.685 0.029
DL5 0.710 0.055 0.696 0.063 0.797 0.043 0.786 0.075 0.798 0.048 0.726 0.051
Total 0.467 0.172 0.432 0.177 0.529 0.174 0.509 0.194 0.575 0.153 0.521 0.149
People aged
over 16 years
out of work
DL1 0.099 0.019 0.204 0.034 0.096 0.019 0.220 0.033 0.086 0.012 0.283 0.033
DL2 0.122 0.024 0.233 0.031 0.115 0.024 0.262 0.035 0.088 0.017 0.308 0.034
DL3 0.146 0.027 0.287 0.042 0.138 0.035 0.345 0.051 0.095 0.015 0.338 0.050
DL4 0.162 0.030 0.333 0.042 0.155 0.044 0.399 0.038 0.095 0.014 0.405 0.051
DL5 0.200 0.046 0.388 0.053 0.197 0.043 0.502 0.082 0.112 0.010 0.369 0.017
Total 0.145 0.038 0.287 0.064 0.138 0.042 0.343 0.088 0.095 0.016 0.342 0.056
People aged 16
or over in
temporary
employment
DL1 0.160 0.023 0.111 0.030 0.182 0.030 0.125 0.016 0.171 0.031 0.137 0.022
DL2 0.191 0.028 0.131 0.037 0.213 0.029 0.153 0.024 0.212 0.021 0.156 0.013
DL3 0.238 0.036 0.167 0.045 0.280 0.046 0.199 0.030 0.232 0.033 0.182 0.034
DL4 0.275 0.036 0.211 0.060 0.352 0.046 0.243 0.039 0.242 0.043 0.203 0.020
DL5 0.326 0.042 0.239 0.063 0.414 0.086 0.302 0.048 0.286 0.047 0.189 0.033
Total 0.238 0.056 0.170 0.060 0.284 0.080 0.201 0.056 0.230 0.042 0.178 0.033
People aged
over 16 years
with low
education level
DL1 0.112 0.033 0.076 0.020 0.126 0.030 0.088 0.029 0.204 0.036 0.126 0.012
DL2 0.187 0.034 0.120 0.023 0.213 0.042 0.128 0.037 0.253 0.024 0.148 0.012
DL3 0.301 0.060 0.198 0.045 0.332 0.058 0.222 0.042 0.354 0.054 0.207 0.045
DL4 0.417 0.040 0.280 0.036 0.419 0.043 0.293 0.045 0.496 0.056 0.279 0.028
DL5 0.517 0.051 0.353 0.047 0.556 0.073 0.410 0.099 0.576 0.051 0.363 0.046
Total 0.304 0.121 0.202 0.086 0.329 0.123 0.223 0.098 0.366 0.115 0.215 0.073
People aged 16
to 29 years with
low education
level
DL1 0.030 0.014 0.018 0.008 0.049 0.023 0.019 0.008 0.070 0.025 0.061 0.029
DL2 0.051 0.017 0.033 0.021 0.073 0.024 0.033 0.018 0.100 0.028 0.051 0.014
DL3 0.092 0.025 0.056 0.031 0.114 0.040 0.083 0.035 0.136 0.028 0.088 0.030
DL4 0.139 0.028 0.103 0.049 0.174 0.037 0.128 0.046 0.226 0.052 0.138 0.030
DL5 0.226 0.058 0.197 0.073 0.287 0.105 0.303 0.161 0.323 0.046 0.188 0.013
Total 0.100 0.059 0.070 0.061 0.127 0.078 0.097 0.094 0.155 0.075 0.096 0.047
Note: a DL: Deprivation level of the census track of residence based on the deprivation index (DI). DL1: DI < P10; DL2: P10 ≤ DI < P25; DL3: P25 ≤ DI < P75; DL4: P75 ≤ DI < P90; DL5: DI ≥
P90; Pq = Percentile q.
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Table A3. Average annual population for the three cities by period, age group, sex, and percentile-based
classification of the deprivation index.
Period
Deprivation
Level (DL) a
0–44 45–64 ≥65
Men Women Men Women Men Women
2000–2007
DL1 27,649 28,172 11,642 14,050 6802 11,100
DL2 61,455 61,018 23,269 26,272 12,625 19,926
DL3 198,787 193,125 71,408 79,503 41,207 62,468
DL4 55,670 51,990 20,026 21,407 12,805 18,065
DL5 34,655 30,895 11,070 11,989 8705 12,994
Total 378,213 365,200 137,416 153,219 82,144 124,552
2008–2015
DL1 23,122 23,128 11,377 13,725 7600 12,044
DL2 69,293 68,923 29,524 33,207 15,390 22,695
DL3 198,369 191,465 85,647 94,619 47,885 70,375
DL4 52,128 48,464 21,396 22,664 13,292 19,839
DL5 35,897 31,253 12,886 12,951 8486 12,493
Total 378,808 363,229 160,829 177,164 92,650 137,443
Note: a DL: Deprivation level of the census track of residence based on the deprivation index (DI). DL1: DI < P10;
DL2: P10 ≤ DI < P25; DL3: P25 ≤ DI < P75; DL4: P75 ≤ DI < P90; DL5: DI ≥ P90. Pq = Percentile q.
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Table A4. Frequencies and percentages a of death for various amenable causes, by sex, period, and level of deprivation (DL) b. All cities together, 2000–2015.
Men
Deprivation Level (DL) b
DL1 DL2 DL3 DL4 DL5 Total
2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015
Septicaemia 12 3 20 12 74 45 20 16 25 6 151 82
4.0% 1.3% 3.2% 2.6% 3.5% 2.6% 3.1% 2.7% 5.2% 1.7% 3.7% 2.4%
Malignant neoplasm of colon and
rectum
73 70 135 108 416 448 126 144 104 85 854 855
24.6% 30.3% 21.8% 23.0% 19.9% 25.8% 19.7% 24.5% 21.8% 24.6% 20.7% 25.4%
Malignant neoplasm of breast 2 0 2 0 1 5 0 2 0 0 5 7
0.7% 0.0% 0.3% 0.0% 0.0% 0.3% 0.0% 0.3% 0.0% 0.0% 0.1% 0.2%
Chronic rheumatic heart disease
0 2 9 8 31 32 10 5 8 2 58 49
0.0% 0.9% 1.5% 1.7% 1.5% 1.8% 1.6% 0.9% 1.7% 0.6% 1.4% 1.5%
Hypertensive disease 9 6 11 25 59 74 19 26 8 17 106 148
3.0% 2.6% 1.8% 5.3% 2.8% 4.3% 3.0% 4.4% 1.7% 4.9% 2.6% 4.4%
Ischaemic heart disease (50% of
deaths)
86 56 175 128 606 446 180 143 117 91 1164 864
29.0% 24.2% 28.2% 27.3% 29.1% 25.6% 28.1% 24.4% 24.5% 26.4% 28.2% 25.6%
Cerebrovascular disease
63 47 128 89 437 314 127 105 105 65 860 620
21.2% 20.3% 20.6% 19.0% 20.9% 18.1% 19.8% 17.9% 22.0% 18.8% 20.9% 18.4%
All respiratory diseases (excl.
pneumonia and influenza)
13 21 47 25 157 126 73 48 41 31 331 251
4.4% 9.1% 7.6% 5.3% 7.5% 7.2% 11.4% 8.2% 8.6% 9.0% 8.0% 7.4%
Pneumonia
10 5 16 21 90 62 28 25 18 14 162 127
3.4% 2.2% 2.6% 4.5% 4.3% 3.6% 4.4% 4.3% 3.8% 4.1% 3.9% 3.8%
Perinatal deaths, all causes 9 5 25 18 56 44 12 14 13 10 115 91
3.0% 2.2% 4.0% 3.8% 2.7% 2.5% 1.9% 2.4% 2.7% 2.9% 2.8% 2.7%
Misadventures to patients during
surgical and medical care
0 2 2 5 1 19 1 6 1 2 5 34
0.0% 0.9% 0.3% 1.1% 0.0% 1.1% 0.2% 1.0% 0.2% 0.6% 0.1% 1.0%
Other amenable causes
20 14 50 30 158 124 45 53 37 22 310 243
6.7% 6.1% 8.1% 6.4% 7.6% 7.1% 7.0% 9.0% 7.8% 6.4% 7.5% 7.2%
Total amenable 297 231 620 469 2086 1739 641 587 477 345 4121 3371
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Table A4. Cont.
Women
Deprivation Level (DL) b
DL1 DL2 DL3 DL4 DL5 Total
2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015
Septicaemia 7 6 8 6 36 29 10 7 13 10 74 58
2.8% 3.2% 1.6% 1.2% 2.2% 2.0% 1.9% 1.6% 3.3% 3.1% 1.9% 2.0%
Malignant neoplasm of colon and
rectum
44 33 86 91 260 280 81 76 52 70 523 550
17.7% 17.7% 16.7% 18.8% 15.6% 18.8% 15.4% 17.4% 13.2% 21.4% 15.6% 18.8%
Malignant neoplasm of breast 86 64 173 173 431 419 138 119 90 57 918 832
34.5% 34.4% 33.5% 35.7% 25.8% 28.2% 26.2% 27.2% 22.9% 17.4% 27.4% 28.5%
Malignant neoplasm of cervix uteri or
cervix uteri and body of uterus
15 11 34 40 128 162 38 48 34 33 249 294
6.0% 5.9% 6.6% 8.2% 7.7% 10.9% 7.2% 11.0% 8.7% 10.1% 7.4% 10.1%
Chronic rheumatic heart disease
6 12 17 11 64 42 27 11 15 13 129 89
2.4% 6.5% 3.3% 2.3% 3.8% 2.8% 5.1% 2.5% 3.8% 4.0% 3.8% 3.0%
Hypertensive disease 3 7 4 11 37 49 23 13 11 11 78 91
1.2% 3.8% 0.8% 2.3% 2.2% 3.3% 4.4% 3.0% 2.8% 3.4% 2.3% 3.1%
Ischaemic heart disease (50% of
deaths)
21 10 39 25 135 62 37 30 36 20 268 147
8.4% 5.4% 7.6% 5.2% 8.1% 4.2% 7.0% 6.9% 9.2% 6.1% 8.0% 5.0%
Cerebrovascular disease
41 23 86 53 309 200 96 63 74 58 606 397
16.5% 12.4% 16.7% 10.9% 18.5% 13.5% 18.2% 14.4% 18.8% 17.7% 18.1% 13.6%
All respiratory diseases (excl.
pneumonia and influenza)
7 4 16 14 72 69 17 20 17 14 129 121
2.8% 2.2% 3.1% 2.9% 4.3% 4.6% 3.2% 4.6% 4.3% 4.3% 3.8% 4.1%
Pneumonia
4 6 12 11 45 34 17 7 18 8 96 66
1.6% 3.2% 2.3% 2.3% 2.7% 2.3% 3.2% 1.6% 4.6% 2.4% 2.9% 2.3%
Perinatal deaths, all causes 5 4 18 18 41 36 8 17 7 10 79 85
2.0% 2.2% 3.5% 3.7% 2.5% 2.4% 1.5% 3.9% 1.8% 3.1% 2.4% 2.9%
Misadventures to patients during
surgical and medical care
1 0 0 8 3 17 1 6 0 2 5 33
0.4% 0.0% 0.0% 1.6% 0.2% 1.1% 0.2% 1.4% 0.0% 0.6% 0.1% 1.1%
Other amenable causes
9 6 23 24 107 87 34 20 24 21 199 158
3.6% 3.2% 4.5% 4.9% 6.4% 5.9% 6.5% 4.6% 6.1% 6.4% 5.9% 5.4%
Total amenable 249 186 516 485 1668 1486 527 437 393 327 3353 2921
Note: a Percentages have been calculated in relation to the total of amenable deaths for the period and DL. b DL: Deprivation level of the census track of residence based on the deprivation
index (DI). DL1: DI < P10; DL2: P10 ≤ DI < P25; DL3: P25 ≤ DI < P75; DL4: P75 ≤ DI < P90; DL5: DI ≥ P90. Pq = Percentile q.
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Table A5. Frequencies and percentages of death according to the large groups of the ICD-10, by sex, level of deprivation, and period. All cities together, 2000–2015.
Men
Deprivation Level (DL) a
TotalDL1 DL2 DL3 DL4 DL5 Total
2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015
I: Infectious and parasitic diseases 60 37 154 124 508 404 192 133 200 108 1114 806 1920
1.7% 1.2% 2.3% 1.9% 2.3% 1.8% 2.8% 2.0% 4.0% 2.3% 2.5% 1.8% 2.2%
II: Neoplasms 1208 1036 2163 2277 7214 7812 2252 2244 1587 1577 14,424 14,946 29,370
34.0% 32.5% 32.3% 34.0% 32.4% 34.6% 32.5% 33.2% 31.8% 34.0% 32.5% 34.1% 33.3%
III: Diseases of the blood, and
inmunity disorders
8 10 18 25 60 56 24 21 9 11 119 123 242
0.2% 0.3% 0.3% 0.4% 0.3% 0.2% 0.3% 0.3% 0.2% 0.2% 0.3% 0.3% 0.3%
IV: Endocrine, nutritional and
metabolic diseases
82 68 154 150 492 518 174 181 123 119 1025 1036 2061
2.3% 2.1% 2.3% 2.2% 2.2% 2.3% 2.5% 2.7% 2.5% 2.6% 2.3% 2.4% 2.3%
V: Mental and behavioural disorders
66 80 147 181 435 659 145 190 95 130 888 1240 2128
1.9% 2.5% 2.2% 2.7% 2.0% 2.9% 2.1% 2.8% 1.9% 2.8% 2.0% 2.8% 2.4%
VI-VIII: Diseases of the nervous
system and organ senses
123 161 195 367 718 1075 216 284 130 188 1382 2075 3457
3.5% 5.1% 2.9% 5.5% 3.2% 4.8% 3.1% 4.2% 2.6% 4.0% 3.1% 4.7% 3.9%
IX: Diseases of the circulatory system 1129 977 2098 1901 6775 6316 1942 1869 1376 1215 13,320 12,278 25,598
31.8% 30.7% 31.4% 28.4% 30.5% 28.0% 28.0% 27.6% 27.6% 26.2% 30.0% 28.0% 29.0%
X: Diseases of the respiratory system 386 401 810 761 2796 2675 940 842 685 627 5617 5306 10,923
10.9% 12.6% 12.1% 11.4% 12.6% 11.9% 13.6% 12.5% 13.7% 13.5% 12.6% 12.1% 12.4%
XI: Diseases of the digestive system 161 148 280 309 1195 1130 400 377 294 251 2330 2215 4545
4.5% 4.6% 4.2% 4.6% 5.4% 5.0% 5.8% 5.6% 5.9% 5.4% 5.2% 5.1% 5.1%
XII: Diseases of the skin and
subcutaneous tissue
10 7 13 8 48 49 9 19 6 12 86 95 181
0.3% 0.2% 0.2% 0.1% 0.2% 0.2% 0.1% 0.3% 0.1% 0.3% 0.2% 0.2% 0.2%
XIII: Diseases of the musculoskeletal
system and connective tissue
12 15 30 34 71 90 30 32 18 21 161 192 353
0.3% 0.5% 0.4% 0.5% 0.3% 0.4% 0.4% 0.5% 0.4% 0.5% 0.4% 0.4% 0.4%
XIV: Diseases of the genitourinary
system
102 99 156 201 509 560 154 197 119 106 1040 1163 2203
2.9% 3.1% 2.3% 3.0% 2.3% 2.5% 2.2% 2.9% 2.4% 2.3% 2.3% 2.7% 2.5%
XV: Pregnancy, childbirth and the
puerperium
9 5 25 18 56 44 12 14 13 10 115 91 206
0.3% 0.2% 0.4% 0.3% 0.3% 0.2% 0.2% 0.2% 0.3% 0.2% 0.3% 0.2% 0.2%
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Table A5. Cont.
Men
Deprivation Level (DL) a
TotalDL1 DL2 DL3 DL4 DL5 Total
2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015
XVI: Certain conditions originating
in the perinatal period
5 7 23 15 48 40 13 16 10 11 99 89 188
0.1% 0.2% 0.3% 0.2% 0.2% 0.2% 0.2% 0.2% 0.2% 0.2% 0.2% 0.2% 0.2%
XVII: Congenital malformations 38 25 78 72 242 231 70 55 56 53 484 436 920
1.1% 0.8% 1.2% 1.1% 1.1% 1.0% 1.0% 0.8% 1.1% 1.1% 1.1% 1.0% 1.0%
XVIII: Symptoms and signs not
elsewhere classified
151 111 347 254 1073 893 364 287 273 206 2208 1751 3959
4.3% 3.5% 5.2% 3.8% 4.8% 4.0% 5.2% 4.2% 5.5% 4.4% 5.0% 4.0% 4.5%
Total
3550 3187 6691 6697 22,240 22,552 6937 6761 4994 4645 44,412 43,842 88,254
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Women
Deprivation Level (DL) a
TotalDL1 DL2 DL3 DL4 DL5 Total
2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015
I: Infectious and parasitic diseases 72 63 112 116 378 385 122 104 110 117 794 785 1579
2.0% 1.6% 1.6% 1.5% 1.8% 1.7% 2.0% 1.6% 2.5% 2.8% 1.9% 1.8% 1.8%
II: Neoplasms 813 849 1610 1763 4504 5201 1339 1502 953 963 9219 10,278 19,497
22.3% 22.0% 22.5% 23.3% 21.7% 23.0% 21.8% 23.4% 22.0% 23.0% 21.9% 23.0% 22.5%
III: Diseases of the blood, and
inmunity disorders
14 20 26 40 98 95 20 32 21 23 179 210 389
0.4% 0.5% 0.4% 0.5% 0.5% 0.4% 0.3% 0.5% 0.5% 0.5% 0.4% 0.5% 0.4%
IV: Endocrine, nutritional and
metabolic diseases
104 104 251 224 737 798 271 242 183 170 1546 1538 3084
2.9% 2.7% 3.5% 3.0% 3.5% 3.5% 4.4% 3.8% 4.2% 4.1% 3.7% 3.4% 3.6%
V: Mental and behavioural disorders
134 214 346 478 902 1249 239 358 163 255 1784 2554 4338
3.7% 5.5% 4.8% 6.3% 4.3% 5.5% 3.9% 5.6% 3.8% 6.1% 4.2% 5.7% 5.0%
VI-VIII: Diseases of the nervous
system and organ senses
184 303 351 636 1068 1793 310 485 205 314 2118 3531 5649
5.1% 7.9% 4.9% 8.4% 5.1% 7.9% 5.0% 7.5% 4.7% 7.5% 5.0% 7.9% 6.5%
IX: Diseases of the circulatory system 1474 1439 2861 2600 8171 7840 2403 2214 1642 1469 16,551 15,562 32,113
40.5% 37.3% 39.9% 34.4% 39.3% 34.7% 39.0% 34.4% 37.9% 35.1% 39.3% 34.9% 37.0%
X: Diseases of the respiratory system 351 360 661 700 2080 2092 593 572 403 370 4088 4094 8182
9.6% 9.3% 9.2% 9.3% 10.0% 9.3% 9.6% 8.9% 9.3% 8.8% 9.7% 9.2% 9.4%
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Table A5. Cont.
Women
Deprivation Level (DL) a
TotalDL1 DL2 DL3 DL4 DL5 Total
2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015 2000–2007 2008–2015
XI: Diseases of the digestive system 188 148 359 298 1106 1056 352 335 269 185 2274 2022 4296
5.2% 3.8% 5.0% 3.9% 5.3% 4.7% 5.7% 5.2% 6.2% 4.4% 5.4% 4.5% 5.0%
XII: Diseases of the skin and
subcutaneous tissue
13 22 24 37 94 129 35 40 22 14 188 242 430
0.4% 0.6% 0.3% 0.5% 0.5% 0.6% 0.6% 0.6% 0.5% 0.3% 0.4% 0.5% 0.5%
XIII: Diseases of the musculoskeletal
system and connective tissue
28 38 70 75 182 215 66 69 50 31 396 428 824
0.8% 1.0% 1.0% 1.0% 0.9% 1.0% 1.1% 1.1% 1.2% 0.7% 0.9% 1.0% 1.0%
XIV: Diseases of the genitourinary
system
114 134 217 270 607 837 166 227 141 136 1245 1604 2849
3.1% 3.5% 3.0% 3.6% 2.9% 3.7% 2.7% 3.5% 3.3% 3.2% 3.0% 3.6% 3.3%
XV: Pregnancy, childbirth and the
puerperium
0 0 0 2 2 3 1 1 0 0 3 6 9
0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
XVI: Certain conditions originating
in the perinatal period
5 4 18 18 41 36 8 17 7 10 79 85 164
0.1% 0.1% 0.3% 0.2% 0.2% 0.2% 0.1% 0.3% 0.2% 0.2% 0.2% 0.2% 0.2%
XVII: Congenital malformations 7 4 16 16 61 41 10 15 7 5 101 81 182
0.2% 0.1% 0.2% 0.2% 0.3% 0.2% 0.2% 0.2% 0.2% 0.1% 0.2% 0.2% 0.2%
XVIII: Symptoms and signs not
elsewhere classified
58 77 104 127 256 259 84 68 44 48 546 579 1125
1.6% 2.0% 1.5% 1.7% 1.2% 1.1% 1.4% 1.1% 1.0% 1.1% 1.3% 1.3% 1.3%
XX: External causes of morbidity and
mortality
80 79 142 167 485 561 137 146 112 76 956 1029 1985
2.2% 2.0% 2.0% 2.2% 2.3% 2.5% 2.2% 2.3% 2.6% 1.8% 2.3% 2.3% 2.3%
Total
3639 3858 7168 7567 20,772 22,590 6156 6427 4332 4186 42,067 44,628 86,695
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Note: a DL: Deprivation level of the census track of residence based on the deprivation index (DI). DL1: DI < P10; DL2: P10 ≤ DI < P25; DL3: P25 ≤ DI < P75; DL4: P75 ≤ DI < P90; DL5: DI ≥
P90. Pq = Percentile q.
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Table A6. Mortality rates (×100,000) for all causes, by sex, age group, deprivation level, and period
under study. All cities together.
Sex Age Deprivation Level (DL) a
Period
2000–2007 2008–2015
Men
0–44
DL1 77.3 55.7
DL2 90.3 49.1
DL3 92.4 57.9
DL4 116.3 76.0
DL5 157.3 88.1
45–64
DL1 580.8 501.0
DL2 586.1 436.5
DL3 678.1 574.0
DL4 797.1 715.1
DL5 985.8 769.3
≥65
DL1 5215.2 4324.3
DL2 5105.4 4383.7
DL3 5125.3 4617.4
DL4 5021.5 4908.0
DL5 5291.3 5301.7
Women
0–44
DL1 39.5 26.5
DL2 42.4 29.0
DL3 45.1 34.3
DL4 52.4 37.7
DL5 61.5 51.2
45–64
DL1 242.9 253.2
DL2 270.2 223.2
DL3 267.6 250.3
DL4 306.6 303.4
DL5 357.7 347.5
≥65
DL1 3690.7 3663.7
DL2 4010.4 3751.5
DL3 3676.7 3584.8
DL4 3745.6 3611.7
DL5 3691.3 3700.3
Note: a DL: Deprivation level of the census track of residence based on the deprivation index (DI). DL1: DI < P10;
DL2: P10 ≤ DI < P25; DL3: P25 ≤ DI < P75; DL4: P75 ≤ DI < P90; DL5: DI ≥ P90. Pq = Percentile q.
Table A7. Mortality rates (×100,000) by susceptible causes, sex, age group, level of deprivation, and
period of study. All cities together.
Sex Age Deprivation Level (DL) a
Period
2000–2007 2008–2015
Men
0–44
DL1 18.1 10.8
DL2 17.7 9.6
DL3 15.1 11.5
DL4 15.7 15.3
DL5 18.0 13.6
45–64
DL1 91.3 96.7
DL2 114.4 74.9
DL3 122.7 101.4
DL4 136.1 142.6
DL5 189.7 131.9
≥65
DL1 316.1 202.3
DL2 316.9 194.1
DL3 347.3 225.0
DL4 344.6 262.4
DL5 371.9 250.4
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Table A7. Cont.
Sex Age Deprivation Level (DL) a
Period
2000–2007 2008–2015
Women
0–44
DL1 10.2 9.7
DL2 13.7 12.3
DL3 13.9 11.2
DL4 17.1 13.7
DL5 15.4 18.8
45–64
DL1 95.2 72.9
DL2 105.6 75.3
DL3 96.7 80.9
DL4 109.8 100.4
DL5 128.3 123.5
≥65
DL1 134.0 91.3
DL2 142.4 119.5
DL3 167.7 124.9
DL4 185.4 127.3
DL5 223.2 152.1
Note: a DL: Deprivation level of the census track of residence based on the deprivation index (DI). DL1: DI < P10;
DL2: P10 ≤ DI < P25; DL3: P25 ≤ DI < P75; DL4: P75 ≤ DI < P90; DL5: DI ≥ P90. Pq = Percentile q.
Table A8. Relative risks of death by amenable causes of death (excluding ischemic heart disease)
according to deprivation level and 95% confidence intervals (95% CI) by age, sex, and period. All
cities together.
Sex Age Deprivation Level (DL) a
2000–2007 2008–2015
RR
95% CI RR 95% CI
Lower Upper Lower Upper
Men
0–44
DL5 1.013 0.660 1.568 1.369 0.768 1.369
DL4 0.765 0.508 1.166 1.525 0.896 1.525
DL3 0.789 0.564 1.137 1.129 0.697 1.129
DL2 0.961 0.655 1.434 0.959 0.555 0.959
DL1 1.000 1.000
45–64
DL5 2.270 1.667 3.128 1.324 0.953 1.324
DL4 1.499 1.111 2.051 1.586 1.186 1.586
DL3 1.333 1.022 1.773 1.106 0.850 1.106
DL2 1.290 0.956 1.765 0.784 0.575 0.784
DL1 1.000 1.000
≥65
DL5 1.269 1.010 1.601 1.179 0.912 1.179
DL4 1.167 0.940 1.457 1.223 0.968 1.223
DL3 1.134 0.939 1.384 1.029 0.839 1.029
DL2 1.009 0.808 1.266 0.865 0.679 0.865
DL1 1.000 1.000
Women
0–44
DL5 1.534 0.913 2.639 2.014 1.196 3.549
DL4 1.675 1.054 2.770 1.379 0.823 2.420
DL3 1.426 0.942 2.274 1.141 0.723 1.920
DL2 1.490 0.940 2.459 1.230 0.747 2.134
DL1 1.000 1.000
45–64
DL5 1.387 1.061 1.818 1.521 1.155 2.012
DL4 1.205 0.945 1.547 1.218 0.942 1.587
DL3 1.042 0.846 1.298 1.003 0.804 1.268
DL2 1.102 0.869 1.408 0.958 0.746 1.241
DL1 1.000 1.000
≥65
DL5 1.613 1.281 2.044 1.796 1.356 2.398
DL4 1.377 1.101 1.733 1.530 1.173 2.018
DL3 1.217 1.000 1.498 1.561 1.235 2.004
DL2 1.052 0.835 1.333 1.432 1.100 1.885
DL1 1.000 1.000
Note: a DL: Deprivation level of the census track of residence based on the deprivation index (DI). DL1: DI < P10;
DL2: P10 ≤ DI < P25; DL3: P25 ≤ DI < P75; DL4: P75 ≤ DI < P90; DL5: DI ≥ P90. Pq = Percentile q.
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Table A9. Relative risks of death by amenable causes (excluding ischemic heart disease) for the period
2008–2015 as compared to the period 2000–2007 and 95% confidence intervals (95% CI) by age, sex, and
deprivation level. All cities together.
Deprivation Level (DL) a Age
Men Women
RR
95% CI
RR
95% CI
Lower Upper Lower Upper
DL1
0–44 0.517 0.280 0.912 0.997 0.528 1.855
45–64 1.041 0.722 1.503 0.888 0.663 1.187
≥65 0.773 0.591 1.008 0.623 0.461 0.836
DL2
0–44 0.516 0.357 0.739 0.823 0.588 1.151
45–64 0.633 0.496 0.805 0.772 0.634 0.939
≥65 0.663 0.543 0.808 0.848 0.697 1.031
DL3
0–44 0.740 0.600 0.909 0.798 0.652 0.975
45–64 0.864 0.761 0.982 0.855 0.762 0.959
≥65 0.701 0.632 0.777 0.799 0.719 0.887
DL4
0–44 1.030 0.710 1.494 0.820 0.570 1.175
45–64 1.102 0.885 1.374 0.897 0.728 1.106
≥65 0.810 0.675 0.970 0.692 0.571 0.838
DL5
0–44 0.698 0.446 1.082 1.309 0.857 2.018
45–64 0.608 0.461 0.798 0.974 0.755 1.256
≥65 0.718 0.574 0.895 0.693 0.557 0.860
Note: a DL: Deprivation level for the census track of residence based on the deprivation index (DI). DL1: DI < P10;
DL2: P10 ≤ DI < P25; DL3: P25 ≤ DI < P75; DL4: P75 ≤ DI < P90; DL5: DI ≥ P90. Pq = Percentile q.
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